Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)

产品名称	Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
目录号	NBR-0938
别名	CD309; FLK1; VEGFR; VEGFR2
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0938-100UG	100ug	￥550	请咨询
NBR-0938-1MG	1mg	￥3500	请咨询
NBR-0938-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
产品编号：NBR-0938
针对靶点：VEGFR2 / KDR / CD309
抗体药商品名：AT001
抗体药描述：AT-001 is an investigational, novel Aldose Reductase Inhibitor (ARI) being developed as an oral therapy for the treatment of Diabetic Cardiomyopathy (DbCM). AT-001 is currently being studied in a Phase 3 registrational study in DbCM.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: KDR
Synonyms: CD309; FLK1; VEGFR; VEGFR2
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis.
Ensembl: ENSG00000128052
Uniprot: P35968